North America Medical Exoskeleton Market to 2031 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Medical Exoskeleton Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Medical Exoskeleton Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Number of Strategic Initiatives

5.2 Market Opportunities

5.2.1 Increasing Prevalence of SCI

5.3 Future Trends

5.3.1 Growing Incidence of Stroke and Musculoskeletal

5.4 Impact of Drivers and Restraints

6. North America Medical Exoskeleton Market Regional Analysis

6.1 North America Medical Exoskeleton Market Overview

6.2 North America Medical Exoskeleton Market Revenue 2020-2031 (US$ Million)

6.3 North America Medical Exoskeleton Market Forecast Analysis

7. North America Medical Exoskeleton Market Analysis – by Component

7.1 Hardware and Software

7.1.1 Overview
7.1.2 Hardware and Software: North America Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Medical Exoskeleton Market Analysis – by Type

8.1 Powered Exoskeleton and Passive Exoskeleton

8.1.1 Overview
8.1.2 Powered Exoskeleton and Passive Exoskeleton: North America Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

9. North America Medical Exoskeleton Market Analysis – by Extremity

9.1 Lower Body Exoskeleton

9.1.1 Overview
9.1.2 Powered Exoskeleton and Passive Exoskeleton: North America Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

9.2 Upper Body Exoskeleton

9.2.1 Overview
9.2.2 Powered Exoskeleton and Passive Exoskeleton: North America Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

9.3 Full Body Exoskeleton

9.3.1 Overview
9.3.2 Powered Exoskeleton and Passive Exoskeleton: North America Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

10. North America Medical Exoskeleton Market – North America Analysis

10.1 North America

10.1.1 North America Medical Exoskeleton Market Breakdown, by Key Country, 2023 and 2031 (%)
10.1.1.1 North America Medical Exoskeleton Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.1.1 US: North America Medical Exoskeleton Market Breakdown, by Component
10.1.1.1.2 US: North America Medical Exoskeleton Market Breakdown, by Type
10.1.1.1.3 US: North America Medical Exoskeleton Market Breakdown, by Extremity

10.1.1.2 Canada: North America Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.2.1 Canada: North America Medical Exoskeleton Market Breakdown, by Component
10.1.1.2.2 Canada: North America Medical Exoskeleton Market Breakdown, by Type
10.1.1.2.3 Canada: North America Medical Exoskeleton Market Breakdown, by Extremity

10.1.1.3 Mexico: North America Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.3.1 Mexico: North America Medical Exoskeleton Market Breakdown, by Component
10.1.1.3.2 Mexico: North America Medical Exoskeleton Market Breakdown, by Type
10.1.1.3.3 Mexico: North America Medical Exoskeleton Market Breakdown, by Extremity

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Medical Exoskeleton Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Ekso Bionics Holdings Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Lifeward, Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 ExoAtlet

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Cyberdyne Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 BIONIK

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 B-Temia Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Hocoma AG

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Myomo Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Rex Bionics Ltd.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights